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Background: Cerebral malaria (CM) is a severe complication of malaria with considerable mortality. In addition to
acute encephalopathy, survivors frequently suffer from neurological sequelae. The pathogenesis is incompletely
understood, hampering the development of an effective, adjunctive therapy, which is not available at present.
Previously, erythropoietin (EPO) was reported to significantly improve the survival and outcome in a murine CM
model. The study objectives were to assess myelin thickness and ultrastructural morphology in the corpus callosum
in murine CM and to adress the effects of EPO treatment in this context.
Methods: The study consisted of two groups of Plasmodium berghei-infected mice and two groups of uninfected
controls that were either treated with EPO or placebo (n = 4 mice/group). In the terminal phase of murine CM the
brains were removed and processed for electron microscopy. Myelin sheaths in the corpus callosum were analysed
with transmission electron microscopy and stereology.
Results: The infection caused clinical CM, which was counteracted by EPO. The total number of myelinated axons
was identical in the four groups and mice with CM did not have reduced mean thickness of the myelin sheaths.
Instead, CM mice had significantly increased numbers of abnormal myelin sheaths, whereas EPO-treated mice were
indistinguishable from uninfected mice. Furthermore, mice with CM had frequent and severe axonal injury,
pseudopodic endothelial cells, perivascular oedemas and intracerebral haemorrhages.
Conclusions: EPO treatment reduced clinical signs of CM and reduced cerebral pathology. Murine CM does not
reduce the general thickness of myelin sheaths in the corpus callosum.
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In semi-immune individuals approximately 1% of all Plas-
modium falciparum infections progress to cerebral malaria
(CM); a cause of substantial morbidity and mortality
worldwide [1]. Though the majority of surviving CM
patients recover completely, a considerable fraction suffer
from neurological sequelae. The sequelae are mostly transi-
ent and reversible, but 20-26% of children suffer from
long-term cognitive impairment [2,3]. Neuronal injury with* Correspondence: casperhempel@gmail.com
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reproduction in any medium, provided the orimpaired axonal transport and cytoskeleton rearrange-
ments are considered to contribute to sequelae [4]. In post
mortem studies almost 40% of CM patients had spots of
demyelination in the brain and brainstem [5,6], commonly
associated with axonal injury [4]. The detection of myelin
pallor and axonal injury has recently been linked to seques-
tration and ring haemorrhages in Malawian children [7].
Demyelination in human CM has been detected with hist-
ology and is considered to be secondary to axonal damage
[4,6]. However, a recent study reports demyelination in
areas without axonal injury but not vice versa and argues
that the pathologies may be independent of each other [7].
For obvious reasons, demyelination in human CM can
only be studied post mortem and may thus not be repre-
sentative of the condition in survivors. Murine CMl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Descriptive data of the grouping of mice and on












UninfSal Saline Saline 37.9 ± 0.4 0 ± 0
UninfEPO Saline 5000 IU EPO/kg 37.3 ± 0.9 0 ± 0
InfSal 104 PbA Saline 26.9 ± 1.1 3.25 ± 0.5
InfEPO 104 PbA 5000 IU EPO/kg 37.2 ± .6 0.5 ± 0.6
All statistics are given as mean ± standard deviation (SD).
Table 2 The clinical score of the mice was performed
according to the table below
Score Observation
0 No discernible clinical signs
1 Hunched back, slightly ruffled fur
2 Very ruffled fur, reduced rate of movement, developing motor
impairments
3 Very ruffled fur, impaired balance/coordination,
hypothermic, severe motor impairments such as ataxia,
hemiplegia and paraplegia, convulsions, fitting
4 Very little movement, convulsions, fitting
5 Loss of consciousness/coma
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possibility to study the processes leading to demyelin-
ation and its functional importance [1]. However in
murine CM, only limited studies on demyelination have
been performed. One study has described demyelination
in the optic nerve [8] and one reported apoptotic oligo-
dendrocytes [9]. In the optic nerve, demyelination pro-
gressively worsened in the periphery of the optic nerve
as clinical signs of CM appeared. In contrast, demyelin-
ation in the central part of the optic nerve was only de-
tectable at a late stage of the infection. In addition,
degenerated axons were apparent in terminally ill
mice [8].
Several studies using the murine CM model have
demonstrated behavioural changes prior to coma as CM
progresses towards its terminal stage [10-14]. Thus,
murine CM causes characteristic behavioural changes
resembling cognitive impairment and loss of conscious-
ness known from human CM [3,13,14]. Furthermore,
mice surviving CM have long-term neurological impair-
ment as human CM survivors do [3,13]. It is known
from multiple sclerosis that severe demyelination and
compromised remyelination cause cognitive impairment
[15-17]. Strikingly, demyelination has received modest
interest in CM. Thus, at present there is no evidence of
a close link between cognitive impairment, axonal injury
and demyelination, and the effects of adjunctive therapy
in murine CM. Murine models are useful in addressing
this aspect given that all pathophysiological aspects can
be examined thoroughly and not only post mortem as is
the case in human CM patients.
In this study, axonal myelination was assessed and
quantified in the corpus callosum (CC) in murine CM by
transmission electron microscopy. Moreover, axonal and
vascular changes were assessed qualitatively. Furthermore,
the effect of erythropoietin (EPO), which in previous mur-
ine studies provided neuroprotection [18-20], on changes
in myelin and axonal structure was assessed.
Methods
Mice, parasites and infection
Pathogen-free, seven-weeks old, female C57BL/6 mice
(Taconic, Ejby, Denmark) were kept under standard con-
ditions with free access to standard pellet diet and water.
Plasmodium berghei ANKA (PbA)-infected erythrocytes
were stored in liquid nitrogen and used for the experi-
ments after a single passage in acclimatized C57BL/6
mice. Mice were split in four groups with four mice in
each (Table 1): uninfected, saline-treated: UninfSal; unin-
fected, EPO-treated: UninfEPO; infected, saline-treated:
InfSal; and, infected, EPO-treated: InfEPO.
Briefly, two groups of mice (InfSal and InfEPO) were
inoculated intraperitoneally (i.p.) with 104 parasitized
erythrocytes in 200 μl isotonic saline. UninfSal andUninfEPO received 200 μl isotonic saline only. Treatments
were injected i.p. on day 4–7 post infection (p.i.) as 200 μl
isotonic saline (control) or 5000 IU/kg recombinant
human erythropoietin (EPO, EprexW, Janssen-Cilag,
Switzerland) diluted in 200 μl saline based on previously
published results [19]. Body temperature was measured
rectally (digital thermometer with rectal probe, Ellab,
Denmark) and parasitaemia determined from thin Giemsa-
stained blood smears by counting 500 erythrocytes.
The mice were observed daily for clinical signs of murine
CM including convulsions, loss of balance and gripping
reflex, paralysis, ruffled fur and lowered body temperature.
A score was assigned from the clinical assessment (Table 2).
On day 8 p.i. all InfSal mice showed clinical signs of CM
and all mice were euthanized on this day.Tissue processing
A deep anaesthesia was induced by an i.p. injection of
10 μl/g body weight of HypnormW/DormicumW [21] and
the mice were then transcardially perfused with hepari-
nized (15,000 U/l) isotonic saline for 30 sec. Tissue was
perfusion-fixed with freshly made Karnovsky’s fixative
(2.5% glutaraldehyde, 2% paraformaldehyde, 0.1 M Na-
phosphate buffer, pH=7.4) for 5 min at 30 ml/min. The
brains were carefully split into two hemispheres through
the midline and immersion-fixed for two hours in the same
fixative before being transferred to 0.1 M Na-phosphate
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optimize fixative strength (glutaraldehyde content in
Karnovsky: 3.5% vs. 2.5%) and immersion fixation time
(two hours vs. 16 h).
Transmission electron microscopy
One hemisphere was chosen at random, studied carefully
and a part encompassing the whole cross-sectional area of
the CC containing all nerve fibres was dissected and em-
bedded in 5% agar. From the CC midline, 150 μm thick
sections were cut on a vibratome perpendicularly to the
long axis of the nerve fibres and stained with 1% toluidine
blue to visualize nuclei and myelin sheaths. Using a dissec-
tion microscope the CC was carefully dissected from the
surrounding tissue and split into parts not longer than
1 mm. Each part was dehydrated according to standard
procedures, post-fixed in 1% Osmiumtetroxide (cat. no.
045384, Alfa Aesar, Germany) in 0.1 M Na-phosphate buf-
fer (pH=7.4) for 60 min, dehydrated in graded series of
ethanol and embedded in epoxy resin (TAAB 812 Epon,
TAAB, United Kingdom) using propyleneoxide as an
intermedium. Ultra thin sections were cut on an ultrami-
crotome perpendicularly to the long axis of the nerve
fibres in CC and collected on formware-coated 1x2 mm
slot grids. The sections were stained with uranyl acetate
(Ultrastain, Laurylab Saint-Fons Cedex, France) for 15
min, rinsed in distilled water and stained with lead citrate
(Ampliqon, Skovlunde, Denmark) for 5 min and washed
again. Pictures were taken at 7,900x magnification for
stereology and at varying magnifications for qualitative
assessments using a Philips CM10 electron microscope
with a Morada digital camera connected to a workstation
with SIS Analysis software (iTEM).
Stereology
A 2-D fractionator design was applied to the digital
images of the ultrathin sections, which contained all the
nerve fibres of the CC cut perpendicular to their longest
axis. The total number of axon profiles, N(Axon), is
given as:
N Axonð Þ ¼ dx  dy
aðframeÞ  Q Axonð Þ ð1Þ
Q(Axon) is the number of axon profiles counted in a
2D unbiased counting frame (Gundersen, 1977) with an
area a(frame) equal to 16 μm2 or 32 μm2. The counting
frames were positioned with a random start and a fixed
distance between them in the x- (dx) and y-direction
(dy) equal to 135 μm. Only axon profiles sampled by the
counting frame were evaluated and at least 300 myelin-
ated axon profiles were assessed in each CC. A practical
example of how to measure the thickness of the myelin
sheaths in transversely cut axons is shown (Figure 1).The myelinated axon profiles were counted and the frac-
tion of profiles with myelin bulbs and other abnormal-
ities were noted in addition to the numbers of axon
profiles undergoing active myelination. The latter was
identified by the dark cytoplasm of an oligodendrocyte
encircling the axon profile completely. The thickness of
the myelin sheaths was calculated from measuring the
diameter of the axon with and without the myelin
sheaths. Furthermore, the g-ratio was calculated
(g-ratio = inner diameter/outer diameter). Since axons
can appear elongated due to a slightly tilted section the
axonal diameter and corresponding adjacent myelin
sheath was always measured as the biggest diameter per-
pendicular to the longest axis of the axon profile. The
microscopist was blinded for all investigations and
assessments. By using design-based stereological sam-
pling of axonal profiles, accurate results with an error
variance of only 0.06 (Coefficient of error) when evaluat-
ing the noise effect were obtained.
Qualitative assessments
The descriptive, histopathological assessments of the CC
were performed after stereological analyses. They com-
prised detailed analyses of axonal myelination. Also, the
axonal architecture was assessed and comprised studies of
neurofilaments, microtubules and mitochondrial morph-
ology. The endothelium was assessed for integrity of tight
junctions, swollenness and intracellular organisation. Peri-
vascular oedemas and haemorrhages were noted if present.
Statistics
For continuous parameters, parametric ANOVA was
used for group-wise comparisons and when appropriate,
a Welch test with Holm correction was performed.
Some parameters including axonal diameters were not
Gaussian distributed and were normalized by log trans-
formation: (x’= log(x + 1)). Intergroup differences were
considered significant if p< 0.05. All statistical analyses
were performed using R (version 2.10.1 for Windows).
Results
Infection and treatment
Parasitaemia increased progressively as previously shown
[20]. EPO treated mice had a slower increase in peripheral
parasitaemia (Figure 2) and at day 8 p.i the parasitaemia
was significantly reduced in InfEPO mice (p< 0.001). At
day 8 p.i., all InfSal mice were terminally ill and all animals
were euthanized. In contrast no InfEPO mice showed signs
of terminal CM. Terminally ill InfSal mice suffered from a
sudden drop in body temperature, which was significantly
lower than what was seen in the other groups (Table 1,
p< 0.001). EPO-treatment improved this parameter signifi-
cantly (p< 0.001) and resulted in a normal body
temperature on day 8 p.i. There were significant differences
Figure 1 Assessing myelination in the CC. (A) Uninfected mouse. The lipid-rich myelin sheaths are electron-dense and myelinated axons appear
as dark rings, also an oligodendrocyte (OL) and a vessel (V) are common findings. Scale bar corresponds to 5 μm. (B) At higher magnification,
unmyelinated axons are seen interspersed between the larger myelinated axons. The counting frame is illustrated. Exclusion lines are in black, inclusion
lines are dotted. Only one myelinated axon would be included in this frame; its inner (I) and outer (O) diameter was measured. Scale bar corresponds
to 500 nm. (C) The total number of axons profiles at day 8 post infection was the same in all groups as depicted on the strip chart. Each dot
represents the total number in one animal. Mean and SD are marked by a horizontal bar and whiskers, respectively.
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p< 0.001). Notably, InfSal mice had poorer performance
compared with InfEPO mice (p< 0.001).
Assessments of myelin sheaths
The number of myelinated axon profiles in the entire CC
was assessed with transmission electron microscopy and
the 2-D fractionator. The total number was similar in the
four groups (Figure 1C, p=0.79). The axonal diameter was
measured and was similar in all four groups (Figure 3A,Figure 2 Progression of parasitaemia. Parasitaemia rose steadily in InfSa
parasitaemia was significantly higher in InfSal mice compared with infEPO
the given day p.i.; the whiskers denote SD.p=0.74). The myelin thickness as well as the axon diam-
eter plus myelin thickness (outer diameter) was different
between the groups (Figure 3B, C; p=0.0039 and 0=0.040,
respectively), but the decrease noticed in the InfEPO group
was not detected in post hoc tests (p> 0.074). There was
no significant change in g-ratio between the four groups
(Figure 3D, p=0.39).
The morphology of the myelin sheaths was assessed
qualitatively (Figure 4). Normal myelin sheaths were
wrapped tightly around the axons as seen in uninfectedl mice whereas it plateaued in InfEPO mice. At day 8 p.i., the
mice (asterisk, p< 0.001). The dots denote the mean parasitaemia at
Figure 3 Quantitative characteristics of the CC myelin sheaths. The inner and outer diameter was measured as depicted in Figure 1B.
(A) There was no significant difference in inner, i.e. axonal, diameter (p= 0.21). Each dot represents the mean diameter in one animal. Mean and
SD is denoted by a horizontal line and whiskers, respectively. (B) There was a significant difference between the groups in outer diameter
(p= 0.040). (C) In correspondence with this, there was also a significant difference in the myelin sheath thickness (p= 0.0039). (D) There was no
change in g-ratio (inner diameter/outer diameter) between the groups (p= 0.39).
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of abnormalities were seen (Figure 4C and 4D). Abnor-
mal myelin sheaths comprised of six main morphological
deviations: (1) blebs of the myelin sheaths, (2) splitting
of myelin sheaths, (3) collapsed myelin sheaths (not
shown), (4) a complete (and often patchy) loss of myelin,
(5) increased periodicity of the individual sheaths, and
(6) very low electron-density of the myelin sheaths. The
latter abnormality gave a pale appearance representing a
lack of unsaturated double bonds in the lipid-rich myelin
sheaths. Splitting of the myelin sheaths was seen as
increased periodicity in one focal spot of the transversely
cut axon while increased periodicity was characterized
by a general, increased distance between the individual
sheaths wrapping the axon. The number of axons with
abnormal myelin appearance was larger in InfSal mice
than in other groups (Figure 4F, p< 0.001). Post hoc
tests revealed that InfSal mice had significantly more
axons with abnormal myelin appearance than uninfected
mice disregarding treatment (p< 0.021). These events
were not significantly more frequent than in InfEPO
mice (p= 0.33); which were similar to uninfected mice
(p> 0.27). The abnormalities were focally distributed
and either one or several, neighbouring axons in a given
area were affected. Axons in uninfected mice also had
few axons without a completely tight myelin sheath but
the abnormalities were restricted to myelin splitting.
The initial phase of myelination, where an electron
dense oligodendrocytic cytoplasm encircled an unmyeli-
nated axon, was seen in all mice (Figure 5A) and no sig-
nificant difference in the number of cell profiles where
myelination took place was found between the groups
(Figure 5B, p= 0.063).
Axonal injury
Axonal injury did not appear as prevalent as myelin
sheath abnormalities. For the purpose of this study thesechanges were only described qualitatively. Generally, the
cytoskeletal organisation was lost in InfSal mice. The
specific type of injury detected was primarily seen as
aggregates of neurofilament, inclusions in the axonal
body and loss of axoplasm (Figure 6B and 6C); the latter
likely due to proteolysis. More rarely, in some axons in
InfSal mice, disrupted mitochondrial christae was noted
(Figure 6B). The axonal injury was focal and most not-
ably seen in InfSal mice. Most axonal injury was seen in
axons with deranged myelin sheaths but in rare cases
inclusions of the axonal body was seen in cells with nor-
mal myelin sheaths. Few axonal injuries were seen in
InfEPO mice, consisting of inclusions of axoplasm
(Figure 6D) and dysorganized neurofilaments (not
shown). No axonal injury was observed in UninfSAL
and UninfEPO (Figure 6A).
Vascular changes
The endothelium in microvessels of the CC was similar in
uninfected mice regardless of treatment. It had a smooth
internal surface and was sealed with well-organized, tight
junctions (Figure 7A and 7B). In InfSal mice the endothe-
lium had several pseudopodic protrusions on its inner sur-
face, and breakdown of tight junctions was noted
(Figure 7C and 7D). These changes corresponded with the
detection of perivascular oedemas, loosening of astrocytic
end feet, adherence of leukocytes, plugging of vessels, and
intracerebral haemorrhages (Figure 7E and 7F). The vas-
cular compartment in InfEPO mice was well preserved
and had a smooth internal surface comparable with unin-
fected mice (Figure 7G) as well as distinct and sealed tight
junctions (Figure 7H).
Discussion
The present study is the first study linking cerebral mye-
lination and adjunct treatment in murine CM. Based on
previous findings of CC infarcts [22,23] and motor-
Figure 4 CM induces pathological changes in myelin sheaths in the CC. (A, B) The CC myelin sheaths in UninfSal (A) and UninfEPO (B) had
normal appearance and compacted closely around the axon. In InfSal the myelin sheaths in the CC had several abnormalities (C, D). (E) In InfEPO
the degree of abnormality was reduced. The most common abnormality was myelin splitting, which was also occasionally seen in uninfected
mice (arrow in A, B, C, D and E). In infected mice, blebs of the myelin sheath (asterisks in C), complete, focal loss (arrowhead in C and D), and
low electron density (L in D) were frequently seen. Increased periodicity was seen in InfSal and InfEPO mice (P in E). The denotations do not
comprise all abnormalities present in each micrograph. Scale bars (A-E) correspond to 1 μm. (F) Quantification of the total number of abnormalities
in the CC revealed a significantly higher number in InfSal mice as shown in the strip chart (*, p< 0.001). Each dot denotes the total number in one
animal. The horizontal bars mark the mean values and the whiskers the SD.
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was selected for ultrastructural assessment. As in human
CM, mice with terminal CM had a significantly increased
frequency of abnormal myelination. EPO treatment abro-
gated the pathophysiological events leading to this out-
come and the myelination pattern was comparable with
uninfected mice. This coincided with EPO treatment re-
ducing clinical severity and peripheral parasitaemia, as
previously shown [19,20]. The mechanism for reducing
peripheral parasitaemia is currently being clarified but is
likely the result of EPO’s effect on immune function [24]
and its stimulating effect on the intraerythrocytic levels of
nitric oxide [25].The changes in axonal myelination were focally distribu-
ted in the CC and a reduced total number of myelinated
axons or thinning of myelin sheaths in terminally ill CM
mice was not seen. Defective myelin was characterized by
focal blebs, splitting, collapsed sheaths and focal loss of
fatty acids of the myelin sheath. The focal distribution of
changes in myelination of the white matter is in line with
the multifocal pathology of human and murine CM
[4,6,8,9,21,26]. Splitting and blebs on the myelin sheaths
were the most frequently observed abnormalities in
infected mice and the former were occasionally seen in
healthy uninfected mice. Intralaminar splitting of myelin
sheaths has been reported in ischemia and may result
Figure 5 Axon profiles being myelinated by oligodendrocytes. (A) Oligodendrocytes encircling and myelinating axon profiles were
frequently noticed in the CC (arrow). Scale bar corresponds to 250 nm. (B) The number of axonal profiles being myelinated in the CC was
identical in all four groups (p= 0.063). Each dot denotes the total number in one animal. The horizontal bar marks mean values and the whiskers
represent SD.
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Recently, widespread focal hypoxia in murine CM was
demonstrated, which was counteracted by EPO treatment,
suggesting a causative role of ischemia in the myelin
damage observed in CM [29]. But the myelin damage may
also result from oligodendroglial apoptosis, which isFigure 6 Qualitative assessment of axonal injury in the CC. Besides the
regardless of treatment have healthy myelinated and unmyelinated axons
of axonal injury were detected including neurofilament aggregates (arrows
(I in B) and disprupted mitochondrial christae (C in B). Unmyelinated axons
axons have dysorganized cytoskeleton (asterisks in B). EPO treatment reduced
(D). Inclusions of the axoplasm were seen (I in D). Scale bars correspond to 50particularly frequent in the CC in this model [9]. Further-
more, demyelination can be caused by reactive oxygen
species and pro-inflammatory cytokines, which are preva-
lent in CM [1,5,15,16,19,30,31]. EPO has been shown to
reduce these processes in murine CM as well as in other
neuropathologic conditions [17-19]. Unpublished,changes in myelination, CM induced axonal injury. Uninfected mice
in the CC (A). In the CC in terminally ill CM mice (B, C), several signs
in B and C), loss of axoplasm (L in B, C), inclusions in the axoplasm
are heavily affected in terminal CM and if not lost, several unmyelinated
axonal injury in the CC in both unmyelinated and myelinated axons
0 nm in A, B and D and 200 nm in C.
Figure 7 CM induces changes to the endothelium and blood–brain barrier in the CC. In uninfected mice regardless of treatment, the
endothelium had a smooth appearance (A (UninfSal) and B (UninfEPO)). Vessel lumen denoted by V in A and B. In contrast, the endothelium of
terminal ill CM mice had pseudopodic protrusions (arrows C and D) and often leukocyte adherence was noted (L in C). In some vessels the tight
junctions were compromised and the astrocytic end feet did not support the endothelium (asterisk in D). Moreover, intracerebral haemorrhages
into the CC were noted (E) and perivascular oedemas were frequent (O in F). In InfEPO mice, the endothelium had a normal appearance (G) and
the tight junctions were intact (arrow heads in H). Scale bars correspond to 5 μm in A, 2 μm in D, E and G, to 1 μm in B, C and F and to 500 nm
in H.
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bellum as well. This may contribute to impaired move-
ment and ataxia in mice with CM. For quantitative studies
the cerebellum is far from ideal due to the heterogenous
and tree-like structures, which make it impossible to avoid
detecting the same nerve fibre twice. These findingsmotivate future studies on linking neuro-motor impair-
ments with the neuropathology observed.
The speed and degree of remyelination may be of im-
portance for recovery from the neurological sequelae
observed in human CM. In this study, it was noted that
infected mice showed a tendency towards an increased
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requires further studies to be substantiated. The
observed profiles being myelinated may either be normal
age-associated myelination of unmyelinated axons [32]
or remyelination after pathological demyelination. The
increase observed in infected mice is likely due to
remyelination induced by EPO and inflammation [17,33]
and the lack of increase in some InfSal mice may be due
to insufficient stimulation of remyelination pathways.
EPO treatment stimulates oligodendrocyte progenitor
cells and improves the functional outcome after experi-
mental stroke [34] and experimental autoimmune en-
cephalitis [17]. Thus, the current study calls for further
characterizations of the effects of EPO on the occur-
rence and recovery from neurological sequelae after
murine CM.
Abnormal myelination was observed more frequently
than axonal damage. This suggests that demyelination is
primary; i.e. takes place prior to axonal injury, but it
may also indicate that oligodendrocytes are more sus-
ceptible than neurons to CM-induced apoptosis, ische-
mia and inflammation. However, the higher axonal
vulnerability to hypoxia compared with glial cells [35]
argues in favour of primary demyelination.
Axonal injury was most frequently seen as dysorga-
nized or loss of the axoskeleton, inclusions of the axo-
plasm, and clearings of the axoplasm. Also focal
periaxonal oedema was seen. These types of injuries
have been described in previous studies of murine CM
[8,9] and are hallmarks of cerebral ischemia. Axoskeletal
changes are of importance since microtubules are essen-
tial for axonal transport and neurofilament maintain
axonal integrity. Axoskeletal impairments can also be
visualized by β-amyloid precursor protein (βAPP) accu-
mulation [36] and indeed, βAPP accumulation has been
shown in CM patients post mortem [6,7,37]. The axonal
diameter was identical in the four groups in the study
signifying that axonal swelling, resulting from cytotoxic
oedema, was negligible.
EPO treatment protected axons from injury. In InfEPO
mice, mitochondria, neurofilaments and microtubules
appeared as in uninfected mice. Moreover, the smaller,
unmyelinated axons were preserved and periaxonal
oedemas were not present in EPO-treated mice. In mur-
ine CM, exogenous EPO reduces neuronal apoptosis and
endogenous, cerebral production of EPO increases dur-
ing the course of an infection highlighting a neuropro-
tective role for EPO in CM [18,19]. Neurons express the
EPO receptor and EPO released from astrocytes can me-
diate cytoprotection in a paracrine fashion [38,39]. In
human CM, the link between cerebral expression of
stress markers and cognitive impairment has been pro-
posed. Thus, the cognitive impairments particularly
associated with CM, including attention and memory,could be closely associated with cerebral axonal injury
and demyelination [2,3,40].
In terminal CM the vascular wall is affected and the
blood–brain barrier (BBB) is compromised [7,22,41]. In CM
mice, the changes in the endothelial compartment included
pseudopodic protrusions, tight junction opening, perivas-
cular oedemas and intracerebral haemorrhages. Pseudopo-
dic endothelial cells may arise from low oxygen [42] and
have been described previously in CM [8,9,41]. Interest-
ingly, EPO-treated mice had a smooth endothelium, no
apparent BBB impairment and no perivascular oedemas;
comparable with that seen in uninfected mice. In a model
of cerebral ischemia, EPO treatment reduced BBB leakage,
increased the expression of tight junction proteins and
reduced the formation of oedemas in the ischemic region
[43]. A compromised BBB likely contributes significantly
to CM pathogenesis and pathology, and BBB damage
increases as CM progresses towards its terminal stage
[44]. In the optic nerve it was noted that a high level of
axonal injury and demyelination was seen in perivascular
regions [8]; similar to human CM [6,45]. Other types of
neuropathology show a link between BBB breakdown and
abnormal myelination [28,46]. Likely, a combination of
hampered perfusion in the cerebral microcirculation, BBB
breakdown including oedemas and intracerebral haemor-
rhages as well as pro-inflammatory cytokines contribute
to the neuropathology seen in this study.
Besides adding to the current understanding of CM
pathology this study, to the authors’ knowledge, is the
first to estimate the total number of myelinated axons in
the murine CC. Previous studies have thoroughly evalu-
ated the fraction of myelinated axons in the CC with
regard to age [32]. Based on these observations, the
seven-weeks old mice enrolled in this study would have
approximately 13% of their CC axons myelinated [32].
The total number of axons in the CC appear to be an
order of magnitude less than what is seen in cats [47].
The estimate given in this study is accurate and precise
due to the sampling principles employed. Furthermore,
the number of cells in the splenial part of CC is posi-
tively correlated with the size of the brain across species
[48] and the estimate obtained alls within the expected
range of myelinated axons in the CC.
Conclusions
In human CM, abnormal myelination is present without
axonal injury, pointing towards a more prominent role of
demyelination than previously believed [7]. Moreover, a
direct link between demyelination and sequelae has been
suggested [49]. Acute CM probably does not result in de-
myelination and hampered remyelination comparable to
that seen in chronic neuropathologies [4] but that does
not preclude an important pathophysiological role of mye-
lin abnormalities in CM. On the ultrastructural level, this
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http://www.malariajournal.com/content/11/1/216study has documented frequent abnormal and defective
myelination in the CC in murine CM. Also, axons and the
endothelium are severely affected by murine CM. EPO
treatment alleviated these CM-induced injuries.
The clinical relevance of EPO as adjunct therapy has
not yet been sufficiently explored. Experimental data
strongly suggests EPO to reduce pathology and severity
[18-20,29] and its use as clinical therapy has recently
been reviewed [50,51]. A clinical study in African chil-
dren showed a negative correlation between plasma EPO
levels and the risk of neurological sequelae [52] and a
clinical safety trial using lower doses of EPO pr. kg
bodyweight than employed in this study showed no ad-
verse effects of the drug [53]. Thus, existing data collect-
ively hint that EPO can reduce the acute CM-induced
pathology as well as its sequelae, and may be used for
adjunct CM therapy.
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